A dose-finding design for dual-agent trials with patient-specific doses for one agent with application to an opiate detoxification trial

In this paper, a dose-finding design for a dual-agent combination trial motivated by an opiate detoxification trial is proposed. The distinguishing feature of the trial is that the (continuous) dose of one compound is defined externally by the clinicians and is individual for every patient.